Ref ID: 18782
Author:
A. De Las Peñas, PhD – Professor, D. Barron, MS – Research Assistant, M. Cuellar, PhD – Professor, I. Castaño, PhD – Professor;
Author address:
Instituto Potosino de Investigacion Cientifica y Tecnologica, San Luis Potosi, San Luis Potosi, Mexico.
Full conference title:
52nd Annual ICAAC
Date: 9 September 2014
Abstract:
Background: Candida glabrata is a commensal yeast that acts as an opportunistic pathogen of inmunocompromised patients. C. glabrata has emerged as the second cause of mucosal, urinary tract and bloodstream fungal infections; 18-26% of all Candida systemic infections in the US. C. glabrata infections are common in patients with diabetes, cancer, and extensive use of antibiotics. C. glabrata infections are associated with high mortality rates and are difficult to treat, since C. glabrata is naturally less susceptible to fluconazole. Thus a rapid and accurate diagnosis is of outmost importance: first to determine the presence of C. glabrata and second, to determine which antifungal to use. There are 3 general diagnostic methods for the identification of C. glabrata: a) selection on specific media and morphology, b) carbohydrate assimilation, and c) molecular methods that include: PCR amplification of the ITS2 variable regions and sequencing, fluorescence in situ hybridization (FISH), identification of specific sequences in particular genes, and detection of specific proteins. It has been shown recently that both C. glabrata clinical isolates and laboratory reference strains, have a high genomic variability and different phenotypes regarding resistance to fluconazole, biofilm formation, and resistance to oxidative stress. This genomic variability has to be taken into consideration when applying single target PCR for diagnostics. Methods: The protocol identifies C. glabrata directly from 1 mL urine and pre-cultured blood samples from hospitalized patients. Our method is based on a multiplex, single PCR reaction of a specific region that is present 9 times throughout the C. glabrata genome. Results: In this work, we present a molecular protocol that identifies 100% of C. glabrata isolates identified by the gold standard method. Conclusions: This method is extremely specific, since PCR reactions with genomic DNA mixtures from different but phylogenetically related yeast, do not amplify. This strategy has not been addressed in any prior report, it is novel, not obvious and subject to industrial application. We have patents protecting the genomic regions of interest.
Abstract Number: M-1668
Conference Poster: y
Conference Year: 2012
Link to conference website: NULL
New link: NULL
Conference abstracts, posters & presentations
-
Title
Author
Year
Number
Poster
-
v
Teclegiorgis Gebremariam [MS]1, Yiyou Gu [PhD]1, Sondus Alkhazraji [PhD]1, Jousha Quran1, Laura K. Najvar [BS]2, Nathan P. Wiederhold [PharmD]2, Thomas F. Patterson [MD]2, Scott G. Filler [MD]1,3, David A. Angulo (MD)4, Ashraf S. Ibrahim [PhD]1,3*,
2024
91
n/a
-
v
Ruta Petraitiene (US)
2024
90
n/a
-
v
Fabio Palmieri (CH), Junier Pilar
2024
89
n/a
-
v
Evelyne Côté (CA)
2024
88
n/a
-
v
Eliane Vanhoffelen (BE)
2024
87
n/a
-
v
Teclegiorgis Gebremariam, Yiyou Gu, Eman Youssef, Sondus Alkhazraji, Joshua Quran, Nathan P. Wiederhold, Ashraf S. Ibrahim
2024
86
n/a
-
v
Thomas Orasch (DE)
2024
85
n/a
-
v
Julien Alex, Katherine González, Gauri Gangapurwala, Antje Vollrath, Zoltán Cseresnyés, Christine Weber, Justyna A. Czaplewska, Stephanie Hoeppener, Carl-Magnus Svensson, Thomas Orasch, Thorsten Heinekamp, Carlos Guerrero-Sánchez, Marc Thilo Figge, Ulrich S. Schubert, Axel A. Brakhage
2024
84
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
83
n/a
-
v
Vasireddy Teja, Bibhuti Saha Hod, Soumendranath Haldar (IN)
2024
82
n/a